TOX DESIGN GROUP, LLC VS. RA PAIN SERVICES, PA VS. CENTRAL TOX, LLC (L-1485-18, CAMDEN COUNTY AND STATEWIDE)

New Jersey Superior Court Appellate Division·Decided December 26, 2019·No. A-4092-18T1·Unpublished

Opinion

NOT FOR PUBLICATION WITHOUT THE APPROVAL OF THE APPELLATE DIVISION This opinion shall not "constitute precedent or be binding upon any court ." Although it is posted on the internet, this opinion is binding only on the parties in the case and its use in other cases is limited. R. 1:36-3.

SUPERIOR COURT OF NEW JERSEY APPELLATE DIVISION

DOCKET NO. A-4092-18T1

TOX DESIGN GROUP, LLC, Plaintiff,

v. RA PAIN SERVICES, PA,

Defendant/Third-Party

Plaintiff/Respondent,

v.

CENTRAL TOX, LLC, MICHAEL SCHMITT, GREGORY KAPLAN, BARRY CHAFFIN, and GARY BUCK,

Third-Party Defendants,

and

@MEDICAL LLC, and CHRISTOPHER RYAN HERTING,

Third-Party Defendants/ Appellants.

Argued November 12, 2019 - Decided December 26, 2019

Before Judges Sumners and Geiger.

On appeal from the Superior Court of New Jersey, Law Division, Camden County, Docket No. L-1485-18.

Michael William Bootier argued the cause for appellants AtMedicalCo, LLC and Christopher Ryan Herting (Buchanan Ingersoll & Rooney PC, attorneys;

Michael William Bootier and Shane P. Simon, on the briefs).

Christopher L. Soriano argued the cause for respondent RA Pain Services, PA (Duane Morris, LLP, attorneys;

Christopher L. Soriano and Samantha L. Haggerty, of counsel and on the brief).

PER CURIAM Third-party defendants AtMedicalCo, LLC1 (AtMedical) and Christopher Ryan Herting, its Chief Executive Officer (collectively the AtMedical Defendants), appeal from an April 12, 2019 Law Division order denying their motion to compel binding arbitration and stay the third-party action filed by defendant/third-party plaintiff RA Pain Services, P.A. (RA Pain) pending the outcome of the arbitration. For the following reasons, we reverse and remand.

1 Improperly pleaded as @Medical, LLC.

A-4092-18T1

I.

RA Pain owns and operates an independent clinical laboratory that provides toxicology and drug testing, medication monitoring, pharmacogenetic testing, and other laboratory services. It sought to engage a manager to provide management and operational services for its laboratory, including billing and collection, finance and accounting, implementation of an information management system, and laboratory design and setup.

On November 2, 2016, RA Pain entered into a Lab Management Services Agreement (LMSA) with AtMedical to provide management and operational services for its laboratory. The LMSA was executed on behalf of RA Pain by its Chief Executive Officer and managing shareholder, Gary Buck, M.D., and on behalf of AtMedical by its Chief Executive Officer, Herting. RA Pain operates in both New Jersey and Pennsylvania while AtMedical operates only in Pennsylvania.

The LMSA contained arbitration and forum selection clauses. Paragraph fifteen of the LMSA (the Forum Selection Clause) states:

Governing Law. This Agreement shall be deemed to have been made and shall be construed and interpreted in accordance with the laws of the State of New Jersey without regard to the state's conflict of laws provisions.

All litigation, claims and actions for the enforcement of this Agreement or otherwise related to this Agreement

A-4092-18T1

shall commenced only in the State or Federal courts located in Camden County, New Jersey, and each of the parties hereto expressly submits to the personal jurisdiction of such courts in any such litigation.

[(Emphasis added).]

Paragraph thirty-two of the LMSA (the Arbitration Clause) states:

Resolution of Disputes. In the event that a dispute arises between two or more Parties under this Agreement or regarding the subject matter of this Agreement, the Parties will first negotiate in good faith for up to thirty (30) days to try and resolve the dispute.

If the dispute cannot be settled through negotiation within thirty (30) days, such dispute shall be settled by final and binding arbitration to be conducted in Philadelphia, Pennsylvania by one arbitrator with at least ten (10) years of experience in health care matters, such arbitration to be conducted in accordance with the commercial arbitration rules of the American Arbitration Association ("AAA").

[(Emphasis added).]

AAA Rule 7 was expressly incorporated into the LMSA. It sets forth the broad jurisdiction of the arbitrator. Subsection (a) of the rule provides:

The arbitrator shall have the power to rule on his or her own jurisdiction, including any objections with respect to the existence, scope, or validity of the arbitration agreement or to the arbitrability of any claim or counterclaim.

Subsection (b) of the rule provides:

A-4092-18T1

The arbitrator shall have the power to determine the existence or validity of a contract of which an arbitration clause forms a part. Such an arbitration clause shall be treated as an agreement independent of the other terms of the contract. A decision by the arbitrator that the contract is null and void shall not for that reason alone render invalid the arbitration clause.

RA Pain was subsequently named as a defendant in an action brought by plaintiff Tox Design Group, LLC. RA Pain, in turn, filed a second amended answer and third-party action against the AtMedical Defendants and six other third-party defendants, including Buck. The third-party complaint alleged the AtMedical Defendants were liable for: (1) civil conspiracy (count I); (2) aiding and abetting breach of fiduciary duty (count IV); (3) breach of the LMSA (count XII); (4) breach of the covenant of good faith and fair dealing (count XIII); (5) promissory estoppel (count XIV); (6) unjust enrichment (count XV); and (7) negligence (count XVI).2 The AtMedical Defendants moved to compel binding arbitration of the claims asserted by RA Pain and stay the third-party action pending the outcome of the arbitration. They contended that the Arbitration Clause required RA Pain to submit its claims to binding arbitration. The AtMedical Defendants further

2 The remaining counts pertain to claims against other third-party defendants not involved in this appeal.

A-4092-18T1

contended that the Forum Selection Clause is "essentially . . . a fallback provision to the arbitration provision" that would be used "in the event that the arbitration is unsuccessful." By way of example, they aver that the Forum Selection Clause requires applications to enforce arbitration subpoenas and awards to be filed in the state or federal court in Camden County. The AtMedical Defendants further argued that when parties incorporate the AAA rules into a contract, the AAA rules "become express terms of the contract itself." They pointed to the headings listed in the LMSA: the Forum Selection Clause falls under "Governing Law," while the Arbitration Clause falls under "Resolution of Disputes."

The AtMedical Defendants emphasize that the LMSA was a contract between two sophisticated commercial entities, not individual consumers. They therefore contend that the enhanced waiver of rights language requirement imposed on consumer contract arbitration provisions do not apply to the LMSA.

Finally, the AtMedical Defendants contend RA Pain provided no facts for the motion court to consider with respect to the validity of the agreement. It submitted no affidavit or certification from any member or representative of RA Pain attesting to any underlying facts. Accordingly, the motion court could not consider the facts asserted in the unsworn statement of counsel.

A-4092-18T1

RA Pain opposed the motion. It argued that the LMSA's Forum Selection Clause and Arbitration Clause could not be complied with at the same time thus making them irreconcilable. It further argued that the parties must have a consensual understanding for an arbitration clause to be enforceable. In that regard, RA Pain asserts on appeal:

Dr. Buck has since been removed from his position at RA Pain due to his involvement in procuring fraudulent agreements, working hand in glove with Christopher Ryan Herting. RA Pain shareholders, apart from Dr.

Buck, never assented to the arbitration provision. . . .

Free access — add to your briefcase to read the full text and ask questions with AI

TOX DESIGN GROUP, LLC VS. RA PAIN SERVICES, PA VS. CENTRAL TOX, LLC (L-1485-18, CAMDEN COUNTY AND STATEWIDE), (N.J. Ct. App. 2019).

TOX DESIGN GROUP, LLC VS. RA PAIN SERVICES, PA VS. CENTRAL TOX, LLC (L-1485-18, CAMDEN COUNTY AND STATEWIDE) (TOX DESIGN GROUP, LLC VS. RA PAIN SERVICES, PA VS. CENTRAL TOX, LLC (L-1485-18, CAMDEN COUNTY AND STATEWIDE)) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Howsam v. Dean Witter Reynolds, Inc.
537 U.S. 79 (Supreme Court, 2002)
Green Tree Financial Corp. v. Bazzle
539 U.S. 444 (Supreme Court, 2003)
Preston v. Ferrer
552 U.S. 346 (Supreme Court, 2008)
Rockel v. Cherry Hill Dodge
847 A.2d 621 (New Jersey Superior Court App Division, 2004)
Linden Board of Education v. Linden Education Ass'n
997 A.2d 185 (Supreme Court of New Jersey, 2010)
Griffin v. BURLINGTON VOLKSWAGEN
988 A.2d 101 (New Jersey Superior Court App Division, 2010)
Curtis v. Cellco Partnership
992 A.2d 795 (New Jersey Superior Court App Division, 2010)
New Jersey Turnpike Authority v. Local 196, I.F.P.T.E.
920 A.2d 88 (Supreme Court of New Jersey, 2007)
Leodori v. Cigna Corp.
814 A.2d 1098 (Supreme Court of New Jersey, 2003)
Delta Funding Corp. v. Harris
912 A.2d 104 (Supreme Court of New Jersey, 2006)
GMAC v. Pittella
17 A.3d 177 (Supreme Court of New Jersey, 2011)
Patricia Atalese v. U.S. Legal Services Group, L.P. (072314)
99 A.3d 306 (Supreme Court of New Jersey, 2014)
Chesapeake Appalachia, LLC v. Scout Petroleum, LLC
809 F.3d 746 (Third Circuit, 2016)
Annemarie Morgan v. Sanford Brown Institute(075074)
137 A.3d 1168 (Supreme Court of New Jersey, 2016)
Henry Schein, Inc. v. Archer & White Sales, Inc.
586 U.S. 63 (Supreme Court, 2019)
Gar Disability Advocates, LLC v. Taylor
365 F. Supp. 3d 522 (D. New Jersey, 2019)
Angrisani v. Financial Technology Ventures
952 A.2d 1140 (New Jersey Superior Court App Division, 2008)
NAACP of Camden County East v. Foulke Management Corp.
24 A.3d 777 (New Jersey Superior Court App Division, 2011)